Drew Pardoll
Impact in
- Immunology top 0.01%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 0.01%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 264
- Immunotherapy and Immune Responses 183
- Immune Cell Function and Interaction 119
- T-cell and B-cell Immunology 83
- Oncology 210
- Cancer Immunotherapy and Biomarkers 141
- CAR-T cell therapy research 75
- Cytokine Signaling Pathways and Interactions 17
- Co-authors
- Suzanne Louise Topalian (30 shared papers)Charles G. Drake (40 shared papers)Hua Yu (18 shared papers)Janis Marie Taube (28 shared papers)Richard Jove (8 shared papers)Robert A. Anders (22 shared papers)Elizabeth M. Jaffee (37 shared papers)Marcin T. Kortylewski (11 shared papers)
- Journals
- The Journal of Immunology (21 papers)Nature Medicine (20 papers)Clinical Cancer Research (19 papers)Proceedings of the National Academy of Sciences (18 papers)Cancer Research (17 papers)
- Partner nations
- United StatesJapanTaiwan
In The Last Decade
Drew Pardoll
451 papers receiving 137.0k citations
Drew Pardoll's Hit Papers
Peers
Comparison fields: 5 of 187
- Immunology 63.0k
- Oncology 75.2k
- Cancer Research 11.5k
- Pathology and Forensic Medicine 8.7k
- Pulmonary and Respiratory Medicine 15.2k
Countries citing papers authored by Drew Pardoll
This map shows the geographic impact of Drew Pardoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew Pardoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew Pardoll more than expected).
Fields of papers citing papers by Drew Pardoll
This network shows the impact of papers produced by Drew Pardoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew Pardoll. The network helps show where Drew Pardoll may publish in the future.
Co-authors
The 25 scholars most cited alongside Drew Pardoll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 457 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The blockade of immune checkpoints in cancer immunotherapy Hit paper breakdown → | 2012 | 11404 |
| 2 | Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer Hit paper breakdown → | 2012 | 10591 |
| 3 | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency Hit paper breakdown → | 2015 | 7794 |
| 4 | Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer Hit paper breakdown → | 2012 | 6699 |
| 5 | Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade Hit paper breakdown → | 2017 | 5274 |
| 6 | STATs in cancer inflammation and immunity: a leading role for STAT3 Hit paper breakdown → | 2009 | 3694 |
| 7 | Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy Hit paper breakdown → | 2015 | 3455 |
| 8 | Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates Hit paper breakdown → | 2010 | 2584 |
| 9 | Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Hit paper breakdown → | 1993 | 2447 |
| 10 | Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy Hit paper breakdown → | 2016 | 2245 |
| 11 | Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy Hit paper breakdown → | 2014 | 2061 |
| 12 | Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab Hit paper breakdown → | 2014 | 1961 |
| 13 | Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape Hit paper breakdown → | 2012 | 1853 |
| 14 | Neoadjuvant PD-1 Blockade in Resectable Lung Cancer Hit paper breakdown → | 2018 | 1647 |
| 15 | Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment Hit paper breakdown → | 2006 | 1578 |
| 16 | Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses Hit paper breakdown → | 2015 | 1567 |
| 17 | A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses Hit paper breakdown → | 2009 | 1471 |
| 18 | Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape Hit paper breakdown → | 2011 | 1414 |
| 19 | Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 Hit paper breakdown → | 2011 | 1372 |
| 20 | The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints Hit paper breakdown → | 2014 | 1254 |
About Drew Pardoll
Drew Pardoll is a scholar working on Immunology, Oncology, Molecular Biology, Genetics and Biotechnology, having authored 457 papers that have together received 140.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (183 papers), Cancer Immunotherapy and Biomarkers (141 papers), Immune Cell Function and Interaction (119 papers), T-cell and B-cell Immunology (83 papers), CAR-T cell therapy research (75 papers), Virus-based gene therapy research (29 papers), Monoclonal and Polyclonal Antibodies Research (24 papers) and Cytokine Signaling Pathways and Interactions (17 papers). The work is most often cited by research in Immunology (63.0k citations), Oncology (75.2k citations), Cancer Research (11.5k citations), Pathology and Forensic Medicine (8.7k citations) and Pulmonary and Respiratory Medicine (15.2k citations). Drew Pardoll has collaborated with scholars based in United States, Japan and Taiwan. Frequent co-authors include Suzanne Louise Topalian, Charles G. Drake, Hua Yu, Janis Marie Taube, Richard Jove, Robert A. Anders, Elizabeth M. Jaffee, Marcin T. Kortylewski, Lieping Chen and Hyam I. Levitsky. Their work appears in journals such as The Journal of Immunology, Nature Medicine, Clinical Cancer Research, Proceedings of the National Academy of Sciences and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.